All Type of News
Celgene Korea urged to further reduce insurance price of Revlimid
Celgene is still in a tug of war with the Health Insurance Review and Assessment Service (HIRA) to make its cancer drug Revlimid more affordable to the national health insurance, although the company already reduced t...
DGIST, Agilent to set up neuroscience center
Daegu Gyeongbuk Institute of Science and Technology (DGIST), the government sponsoring institute, said Wednesday it a memorandum of understanding with the U.S. based Agilent Technologies to set up a national neuroscie...
Sleep disorder victims surge
The number of people suffering from sleep-related problems has increased by 17 percent over the past five years, a government report said yesterday.
According to the Health Insurance Review and Assessment Service ...
Multinational drug firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to the data comp...
Lipitor sales top 31.1 billion won in first half
Pfizer’s Lipitor posted 31.1 billion won in its first-half sales in domestic prescription drugs market, strengthening its supremacy as Korea’s leading anti-arteriosclerosis agent, according to data compiled by Yakup.c...
The Shop, Pharmsnet compete on cyber drug market
The Shop, an online shopping mall promoted by Daewoong Pharmaceutical, is about to duke it out with a market leader Pharmasnet for a bigger pie as the Shop is gearing up to strengthen its presence in local pharmacy ma...
Government to award certificate for innovative pharmaceutical firms
The Ministry of Health and Welfare will hold a ceremony today to offer an official certificate for 43 drug companies selected as innovative pharmaceutical firms.
In the ceremony where health related government offi...
What makes Green Cross’s Shinbaro promising drug?
Osteoporosis is a massive concern for older women. Standard current treatments for osteoporosis can reduce bone fractures significantly. But they have been associated with a range of side effects, including stomach an...
Local impotence drug market to reach 150 billion won in size
Korean pharmaceutical firms are gearing up to enter the current 100 billion won anti-impotence drug market as the main patent of the market leader, Pfizer’s Viagra, expired on May 18.
According to the Korea Food an...
25 medicines included in Korea’s Green List
A total of 25 drugs, including Bristol-Myers Squibb’s Baraclude, Dongwha’s Milican. and Chong Kun Dang’s Camtobell, are currently listed in the Green List, according to the data compiled by the Korea Food and Drug Adm...
